Experience of Using a Semielemental Formula for Home Enteral Nutrition in Children
A Multicenter Cross-sectional Study
This study was not registered since it is a retrospective study.
This work was supported by Nestlé Health Science.
F.G. and D.G. were scientific advisors of this study and received fees from Nestlé Health Science. J.G. is an employee at Nestlé Health Science. The remaining authors report no conflicts of interest.
ABSTRACT
Objectives:
The use of semielemental diets concerns a small proportion of children on enteral nutrition whose characteristics have never been reported. Our aim was to describe a cohort of patients on home enteral nutrition with Peptamen Junior, including the tolerance and nutritional efficacy of this product.
Methods:
We performed a retrospective multicenter survey on a cohort of patients receiving this semielemental diet at home between 2010 and 2015 in 14 tertiary pediatric French centers. We recorded at baseline, 3, 6, and 12 months, and then every year the anthropometric characteristics of the patients, indications and modalities of administration of the diet, and the tolerance and adverse events.
Results:
We recruited 136 patients ages 9.8 ± 4.4 years at baseline. Mean body mass index z score was −1.0 ± 1.8; mean height z score was −1.1 ± 1.9. The main underlying diseases were digestive (35.3%), neurological (33.1%), and hematological (19.9%). The indications for a semielemental diet were failure of another diet in 70 patients (51.9%), severe malnutrition in 19 (14.1%), cystic fibrosis in 11 (8.1%), and switch from parenteral nutrition in 11 (8.1%). Side effects were observed in 39.2% of the patients, and required medical attention in 8.2%. Body mass index improved or remained normal in 88.3% of children.
Conclusions:
This semielemental diet seems to be well tolerated and efficient in the setting of home enteral nutrition in children with complex diseases featuring malabsorption and/or after failure of polymeric diet.
